The growing burden of cardiometabolic diseases is reshaping the future of healthcare worldwide. From diabetes and obesity to cardiovascular and kidney disease, these interconnected conditions continue to challenge clinicians, researchers, and healthcare systems alike. Against this backdrop, the International Symposium on Cardiometabolic Risk and Vascular Disease: From Mechanisms to Treatment will bring together global experts in Stockholm, Sweden, on 16–17 June 2026.
Hosted at the prestigious Sune Bergström Hall at Karolinska University Hospital and chaired by Professor Francesco Cosentino, the symposium aims to bridge the gap between scientific discovery and real-world clinical care.
| Date | Time | Session / Event |
|---|---|---|
| 16 June 2026 | 08:00 AM – 08:30 AM | Registration of Participants |
| 16 June 2026 | 08:30 AM – 08:45 AM | Welcome Addresses & Introduction |
| 16 June 2026 | 08:45 AM – 09:00 AM | Fondazione Menarini Presentation |
| 16 June 2026 | 09:00 AM – 10:40 AM | Session I: Emerging Risk Factors and Novel Disease Mechanisms |
| 16 June 2026 | 11:00 AM – 11:30 AM | Keynote Lecture: Cardiovascular Risk Reduction in Children |
| 16 June 2026 | 11:30 AM – 01:10 PM | Session II: Obesity – Causes, Mechanisms and Management |
| 16 June 2026 | 02:10 PM – 03:50 PM | Session III: Clinical Assessment of Cardio-Renal-Metabolic Disease |
| 16 June 2026 | 04:10 PM – 06:15 PM | Session IV: Optimising Chronic Coronary Syndromes Management |
| 17 June 2026 | 08:30 AM – 10:10 AM | Session V: The Changing Horizon in Lipid Lowering Treatment |
| 17 June 2026 | 10:30 AM – 12:10 PM | Session VI: Artificial Intelligence for Cardiometabolic Health |
| 17 June 2026 | 12:10 PM – 12:40 PM | Keynote Lecture: Preventing CV Risk in Prediabetes |
| 17 June 2026 | 01:40 PM – 03:20 PM | Session VII: Management of HFpEF |
| 17 June 2026 | 03:40 PM – 06:00 PM | Session VIII: Evidence-Based Treatment of Cardiometabolic Disease |
Why Cardiometabolic Health Matters More Than Ever
Cardiometabolic risk is one of the leading drivers of atherosclerotic cardiovascular disease (ASCVD), impacting millions of people globally. Conditions such as type 2 diabetes (T2D), chronic kidney disease (CKD), obesity, hypertension, and dyslipidemia are deeply interconnected and often coexist in the same patient.
Recent advances in medicine have shown that innovative therapies — including SGLT-2 inhibitors, GLP-1 receptor agonists, mineralocorticoid receptor antagonists, and dual GIP/GLP-1 agonists — can significantly improve cardiovascular and renal outcomes beyond traditional glucose control.
The symposium is designed to explore these breakthroughs while promoting multidisciplinary collaboration across cardiology, endocrinology, nephrology, and metabolic medicine.
Key Scientific Themes
The two-day scientific programme will focus on some of the most pressing topics in cardiometabolic medicine, including:
- Emerging cardiovascular risk factors
- Obesity and inflammation
- Advanced imaging and biomarkers
- Lipid-lowering innovations
- Artificial intelligence in healthcare
- HFpEF management
- Lifestyle and preventive medicine
- Precision therapeutics in diabetes and vascular disease
One particularly timely session will address the “Emerging role of micro- and nanoplastics in cardiovascular disease,” highlighting how environmental factors are becoming increasingly relevant in vascular health research.
Another standout theme is the growing role of artificial intelligence in cardiometabolic care, with discussions covering data-driven medicine, digital empowerment, and the benefits and risks of AI in healthcare.
World-Class Faculty and International Collaboration
The symposium features an internationally renowned faculty from leading academic and clinical institutions across Europe, North America, and the Middle East. Experts from Stockholm, London, Toronto, New York, Berlin, Milan, Oxford, Copenhagen, and many other cities will contribute to discussions on the future of cardiometabolic medicine.
Notable speakers include:
- Valentin Fuster
- Francesco Cosentino
- Subodh Verma
- Charalambos Antoniades
- Lars Ryden
- Gianluigi Savarese
- Victoria Delgado
Hybrid Participation and Free Registration
To maximize accessibility, the symposium will be conducted as a hybrid event, allowing participants to attend either in person or via live streaming. Registration is free for both formats.
Participants can register through the Fondazione Menarini website or mobile application, where they can also access event schedules, livestreams, and post-event presentation materials.
Looking Ahead
As cardiometabolic diseases continue to evolve into one of the most complex global health challenges, collaborative scientific forums like this symposium are essential for accelerating innovation and improving patient outcomes. By connecting cutting-edge research with clinical practice, the event promises to deliver valuable insights into the future of prevention, diagnosis, and treatment.
The International Symposium on Cardiometabolic Risk and Vascular Disease 2026 represents more than a scientific meeting — it is a platform for shaping the next generation of cardiometabolic care.
Official Link – https://drive.google.com/file/d/1RKtFO7-w9b-L_Q4Kh3j3J8JANil1HY0j/view?usp=sharing
